NIH Finance: Zero Incremental Budget for New Clinic

The National Institutes of Health Clinical Center Research Hospital board chair, Jack Leslie, told members that the new vaccine injury clinic launched by Health Secretary Robert F. Kennedy Jr. adds no new budget line or physical space to the institution. Leslie made the financial observation during a regularly scheduled board meeting, noting that the clinic operates without additional funding.

The clinic opened following a ribbon-cutting ceremony where Kennedy appeared unexpectedly. The event featured a panel of individuals who reported vaccine-related injuries. These speakers sat behind signs labeled "vaccine injured" and conversed with Kennedy and other senior administration officials. The ceremony marked the public debut of the facility, which Leslie argued could affect the hospital's public standing.

Leslie has overseen the hospital, a facility often described as a "house of hope" for patients with rare conditions. He spent approximately six minutes addressing the board before moving to the formal agenda. His comments focused on the gap between the high-profile launch and the clinic's operational reality. He stated that the board's silence on the matter would represent a failure in its advisory duties.

Hospital CEO Jonathan Green supported Leslie's account of the clinic's structure. Green explained that the NIH has studied vaccine safety and efficacy for decades. He characterized the new clinic as a single protocol within the existing research framework rather than a separate division. Green noted that the work on vaccine harms continues as part of the institution's long-standing mission.

Leslie clarified that his criticism targets the public presentation of the clinic rather than the scientific process itself. He affirmed that serious vaccine reactions are rare but real. He added that individuals who believe they were injured should be taken seriously by medical professionals. His remarks distinguished between the political visibility of the launch and the clinical nature of the research.

The board meeting serves as a checkpoint for the hospital's operations. Leslie and Green provided their assessments of the new clinic's integration into the hospital's existing structure. The clinic currently functions without the dedicated resources that a new standalone department would typically require. The leadership team maintains that the clinic fits within the current scope of NIH research activities.

The hospital continues to serve patients who have exhausted other treatment options. The board will review the clinic's performance as part of its ongoing oversight responsibilities. No new financial allocations have been announced for the facility since its opening. The institution's management team will monitor the clinic's output alongside other research protocols.